Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like Why High-Flying M&A Target Tesaro Recently Lost More Than a Quarter of Its Value April 25, 2017 Prolacta Bioscience Names New Members And Expands Resources For Dietitians And Clinicians March 30, 2017 <b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017
Prolacta Bioscience Names New Members And Expands Resources For Dietitians And Clinicians March 30, 2017
<b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017
